SARS-CoV-2 Antibody ELISA
Device
OraSure Technologies Inc.
Total Payments
$275,882
Transactions
5
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2020 | $275,882 | 5 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $275,882 | 5 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Sample Acquisition Protocol for Development of Tests to Detect Antigens or Antibodies to Coronavirus | OraSure Technologies Inc. | $275,882 | 0 |
Top Doctors Receiving Payments for SARS-CoV-2 Antibody ELISA
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Allentown, PA | $275,882 | 5 |
Ad
Manufacturing Companies
- OraSure Technologies Inc. $275,882
Product Information
- Type Device
- Total Payments $275,882
- Total Doctors 0
- Transactions 5
About SARS-CoV-2 Antibody ELISA
SARS-CoV-2 Antibody ELISA is a device associated with $275,882 in payments to 0 healthcare providers, recorded across 5 transactions in the CMS Open Payments database. The primary manufacturer is OraSure Technologies Inc..
Payment data is available from 2020 to 2020. In 2020, $275,882 was paid across 5 transactions to 0 doctors.
The most common payment nature for SARS-CoV-2 Antibody ELISA is "Unspecified" ($275,882, 100.0% of total).
SARS-CoV-2 Antibody ELISA is associated with 1 research study, including "Sample Acquisition Protocol for Development of Tests to Detect Antigens or Antibodies to Coronavirus" ($275,882).